SC

Phantom CNC Systems Releases CNC Industry-Disrupting 4x4 Table with 8-Plate Automatic Tool Changer, and They Call It Atomic

Retrieved on: 
星期四, 十一月 9, 2023
Atomic, ATC, Dust, VFD, Collet, CNC, Phantom of the Paradise, Social, Torque, Atmosphere of Earth, Collection, SC, Machine shop, Phantom

The CNC Router 4x4 series is now available with an automatic tool changer.

Key Points: 
  • The CNC Router 4x4 series is now available with an automatic tool changer.
  • The Atomic has a small footprint, but packs a huge punch with sturdiness and quality of cuts.
  • Phantom's machines have a tolerance of +/- 0.03 across 12' feet making these 4' x 4' machines extremely accurate.
  • "You can't compare this with any other 4X4 CNC machine with an automatic tool changer in the market.

SC Johnson Demonstrates Industry Leadership in Plastic Packaging in Latest Global Commitment Progress Report

Retrieved on: 
星期三, 十一月 8, 2023
MacArthur, Jean Racine, United Nations Environment Programme, MacArthur Foundation, Organization, S. C. Johnson & Son, John Macarthur (wool pioneer), Household, Annual report, Personal care, Plastic, Ellen, SC, Recycling

The company leads its industry in post-consumer recycled plastic and virgin plastic reduction

Key Points: 
  • According to the Ellen MacArthur Foundation, the world is still not on course to eliminate plastic waste and pollution.
  • Percent of plastic packaging that is recyclable, reusable or compostable: As noted in the report, SC Johnson is making progress in moving toward refill/reuse models.
  • As a result of innovation in durable dispensers, in-store refill systems, refillable bottles and concentrates, 9% of our plastic packaging is reusable.
  • And businesses can't do it alone," said Fisk Johnson, Chairman and CEO of SC Johnson.

Repligen Launches TangenX® SC as First-to-Market Holder-Free Self-Contained TFF Device

Retrieved on: 
星期四, 十一月 2, 2023
Filtration, Dicarboxylic acid, Repligen Corporation Award in Chemistry of Biological Processes, Chromatography, CNC, Senior, Repligen, Cross-flow filtration, Risk, Spacecraft, Ultrafiltration, Safety, PRO, TFF, SC, Cassette tape

WALTHAM, Mass., Nov. 02, 2023 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced the commercial launch of TangenX® SC, the industry’s first holder-free, self-contained Tangential Flow Filtration (TFF) device.

Key Points: 
  • WALTHAM, Mass., Nov. 02, 2023 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced the commercial launch of TangenX® SC, the industry’s first holder-free, self-contained Tangential Flow Filtration (TFF) device.
  • Christine Gebski, Senior Vice President, Filtration and Chromatography at Repligen, said, “TangenX SC pushes the boundaries of TFF innovation, offering clear advantages to virtually any user of flat sheet TFF.
  • The holder-free TangenX SC device simplifies and streamlines downstream flat sheet UF/DF processes like never before.
  • Designed with the same flow path length and channel geometry as traditional cassettes, TangenX SC allows users to seamlessly transition from traditional cassettes.

Carahsoft Showcases Cutting-Edge Solutions From Its Robust AI, Data Analytics and HPC Solutions Portfolios at SC23 in Denver, November 12-17, 2023

Retrieved on: 
星期二, 十月 31, 2023
Policy, Colorado Convention Center, Carahsoft, Data collection, HPC, Workforce, Trust (social science), Conference, Research, Artificial intelligence, University, ACM/IEEE Supercomputing Conference, Culture, Government agency, SC, Retail

RESTON, Va., Oct. 31, 2023 (GLOBE NEWSWIRE) -- Carahsoft Technology Corp. , The Trusted Government IT Solutions Provider®, offers hundreds of proven data collection, analysis and visualization tools from 90+ technology providers that automate analytical processes, provide real-time access to information and enable users to derive meaning insights from data.

Key Points: 
  • RESTON, Va., Oct. 31, 2023 (GLOBE NEWSWIRE) -- Carahsoft Technology Corp. , The Trusted Government IT Solutions Provider®, offers hundreds of proven data collection, analysis and visualization tools from 90+ technology providers that automate analytical processes, provide real-time access to information and enable users to derive meaning insights from data.
  • At the 35th anniversary of this annual event, decision makers across these markets will gather to network, engage with technology demos, receive professional development advice and glean insights from top thinkers in the HPC community.
  • Discussions will also cover overlapping research domains such as artificial intelligence, biomedicine, quantum computing, HPC’s role in changing research and driving a new workforce and its impact on the culture.
  • The SC technical program will educate participants through sessions, panels and workshops on best practices for:

Aura Biosciences Receives FDA Agreement Under Special Protocol Assessment (SPA) for CoMpass Phase 3 Clinical Trial of Belzupacap Sarotalocan (Bel-sar) in Early-stage Choroidal Melanoma

Retrieved on: 
星期一, 十一月 6, 2023
Science, Biotechnology, Research, Pharmaceutical, Oncology, Health, FDA, Clinical Trials, Neoplasm, Wills Eye Hospital, Șaeș, CM, Food, I Am the Moon, AAO, Compass, Cohort, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Radiation, American Academy, American Academy of Ophthalmology, Annual general meeting, Paratriathlon, Safety, Visual acuity, SPA, Patient, SC, VDC, Thomas Jefferson University, Pharmaceutical industry, Ophthalmology

The results were presented at the American Academy of Ophthalmology (AAO) 2023 Annual Meeting in San Francisco, California.

Key Points: 
  • The results were presented at the American Academy of Ophthalmology (AAO) 2023 Annual Meeting in San Francisco, California.
  • The safety profile continues to be favorable with no treatment-related serious adverse events or significant adverse events.
  • The Phase 3 trial is designed as a superiority trial comparing bel-sar versus sham.
  • The ongoing Phase 1 multi-center, open-label clinical trial is expected to enroll approximately 19 adult patients.

Upstream Bio Announces Positive Phase 1b Interim Data in Asthma and Company Progress Toward Phase 2

Retrieved on: 
星期二, 十月 24, 2023
Biotechnology, Pharmaceutical, Health, Clinical Trials, PD, Bio, Nitric acid, Emax, MD, MAD, Inflammation, Volunteering, Caregiver, Thymic stromal lymphopoietin, Sinusitis, Partnership, Asthma, Research and development, Congress, Safety, Polyp (medicine), Patient, SC, Pharmaceutical industry, Research

Upstream Bio , a clinical-stage biotech company advancing new therapies to treat inflammation, today announced positive interim results in its Phase 1b clinical study of UPB-101, a thymic stromal lymphopoietin receptor (TSLPR) inhibitor.

Key Points: 
  • Upstream Bio , a clinical-stage biotech company advancing new therapies to treat inflammation, today announced positive interim results in its Phase 1b clinical study of UPB-101, a thymic stromal lymphopoietin receptor (TSLPR) inhibitor.
  • The Phase 1b study is a randomized, double-blinded, placebo-controlled multiple ascending dose (MAD) study with subcutaneous (SC) administration​ conducted in asthma patients.
  • The interim data results demonstrated favorable safety, tolerability, immunogenicity, pharmacokinetic (PK) and pharmacodynamic (PD) markers that strongly support moving to Phase 2.
  • “The Upstream team is taking swift steps to move into our global Phase 2 studies in severe asthma and CRSwNP by Q1 2024.

Numab Therapeutics Announces First Patient Dosed in Phase 1 Multiple Ascending Dose (MAD) Study of NM26 for Moderate to Severe Atopic Dermatitis

Retrieved on: 
星期四, 十月 19, 2023
Science, Biotechnology, Research, Pharmaceutical, Oncology, Health, Clinical Trials, Other Health, AD, Itch, Therapy, Skin, MAD, Inflammation, SAD, Pharmacokinetics, Numabe Station, Safety, Atopic dermatitis, European, Patient, SC, Pharmaceutical industry, Vaccine

Numab Therapeutics AG (Numab), a clinical stage biotechnology company advancing a proprietary pipeline of immunology and oncology therapeutics, announced today that the first patient has been dosed in the multiple ascending dose (MAD) study of the Phase 1a/b clinical trial of NM26, a first-in-class bi-specific antibody for the treatment of moderate-to-severe atopic dermatitis (AD).

Key Points: 
  • Numab Therapeutics AG (Numab), a clinical stage biotechnology company advancing a proprietary pipeline of immunology and oncology therapeutics, announced today that the first patient has been dosed in the multiple ascending dose (MAD) study of the Phase 1a/b clinical trial of NM26, a first-in-class bi-specific antibody for the treatment of moderate-to-severe atopic dermatitis (AD).
  • The MAD study in AD patients is a planned continuation of the Company’s ongoing single ascending dose (SAD) portion of the Phase 1a/b trial in healthy volunteers.
  • “Dosing the first patient with NM26 represents a major milestone for Numab as we advance development of NM26 in atopic dermatitis and potentially other inflammatory and immune-mediated diseases,” said David Urech, Ph.D., Founder and Chief Executive Officer of Numab Therapeutics.
  • In the United States and the European Union markets, approximately 17-26 million patients suffer from moderate-to-severe AD.

Maya Brenner and Frank Lloyd Wright Foundation Join Forces to Design Two Classic Yet Modern Jewelry Collections

Retrieved on: 
星期三, 十月 18, 2023
Jewelry, Fashion, Luxury, Retail, Specialty, Gold, Midway Gardens, Life, Architecture, Glass, Taliesin West, Sunlight, Multimedia, Learning, Taliesin, Jewellery, Liberty (magazine), Collection, SC, Virtue, Interior design

In a unique collaboration that blends the worlds of art, architecture and fashion, celebrity jewelry designer Maya Brenner has partnered with the Frank Lloyd Wright Foundation to design a capsule collection that pays homage to the legendary 20th century architect’s genius and his timeless creations.

Key Points: 
  • In a unique collaboration that blends the worlds of art, architecture and fashion, celebrity jewelry designer Maya Brenner has partnered with the Frank Lloyd Wright Foundation to design a capsule collection that pays homage to the legendary 20th century architect’s genius and his timeless creations.
  • View the full release here: https://www.businesswire.com/news/home/20231018864113/en/
    Jewelry designer Maya Brenner has partnered with the Frank Lloyd Wright Foundation to design a capsule collection.
  • (Photo: Maya Brenner)
    The Maya Brenner x Frank Lloyd Wright Foundation collaboration is comprised of two distinct jewelry collections, Virtues and Racine.
  • “One of the primary goals of this collaboration is to introduce those who may be unfamiliar with Frank Lloyd Wright to his remarkable architectural and design legacy,” explained Maya Brenner.

Santander Consumer Supports Local STEM Students ahead of the FORMULA 1 Lenovo United States GRAND PRIX 2023 in Austin

Retrieved on: 
星期三, 十月 18, 2023
Professional Services, Education, Sports, Motor Sports, Finance, University, Science, University of Texas at Austin, Mathematics, University of Texas at Dallas, Banco Santander, Consumer, Lars Magnus Ericsson, Leclerc, Workforce, Carbon, Cockrell School of Engineering, Formula One, Multimedia, Learning, Longhorn, Student, Santander Consumer Bank (Deutschland), Ferrari, Henson v. Santander Consumer USA Inc., Formula, SC, Scuderia, Computer science, Management, Nursing, STEM, Engineering, Scuderia Ferrari

View the full release here: https://www.businesswire.com/news/home/20231018751705/en/

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20231018751705/en/
    Ferrari Formula 1 Driver Charles Leclerc joins members of the Longhorn Racing team at UT Austin.
  • Santander Consumer announced today it will become a title sponsor of the Longhorn Racing team, as part of $500,000 in grants benefiting local students.
  • Leclerc's visit ahead of the Formula 1 Lenovo United States Grand Prix 2023 in Austin has been a source of inspiration to push the program forward with top talent.
  • Banco Santander and Formula 1 have a long-standing relationship with the bank as a partner of the sport from 2007 to 2017.

Stackr Brings Free Play to the Masses with its Social Casino Platform

Retrieved on: 
星期六, 十月 21, 2023
VIP, Table, GC, Corrosion engineering, SC, Video game, Crash

PHOENIX, Oct. 21, 2023 /PRNewswire-PRWeb/ -- For online gamers looking for a free experience that offers exciting new games, generous registration bonuses, and unparalleled customer support, a new player has entered the casino gaming universe.

Key Points: 
  • Stackr , the first US-based owned and operated social casino platform, recently opened its virtual doors for business.
  • As a social gaming site, Stackr aims to put its members and their experience at the forefront.
  • "We wanted to create a social gaming experience unlike anything else on the market," said Rich Davis, Stackr creator.
  • To learn more and register for Stackr's free social casino platform, visit www.stackr.us.